Study to evaluate the addition of an experimental drug, CC-90010, to the usual treatment of brain cancer after surgery

Status

Completed

Phases

Phase 1

Study type

Interventional

Source

EU CTIS

Registry ID

CTIS2024-511171-15-00

Acronym

CC-90010-GBM-002

Enrollment

216

Registered

2024-04-03

Start date

2020-07-06

Completion date

2024-04-18

Last updated

2024-07-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Subjects with newly diagnosed WHO Grade IV glioblastoma (ndGBM) who have undergone complete or partial tumor resection

None listed

Sex/Gender

All

Age

18 Years to No maximum

Denmark, Italy, Netherlands, Norway, Spain, Sweden

None listed

Source: EU CTIS · Data processed: Feb 4, 2026